Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 12/20 | 0.67 |
| ▸ | MAOA | P21397 | 4/20 | 0.67 |
| ▸ | CYSLTR2 | Q9NS75 | 2/20 | 0.63 |
| ▸ | BCHE | P06276 | 1/20 | 0.62 |
| ▸ | HSP90AA1 | P07900 | 1/20 | 0.60 |
| ▸ | APP | P05067 | 1/20 | 0.59 |
| ▸ | NR1H4 | Q96RI1 | 1/20 | 0.56 |
| ▸ | CYSLTR1 | Q9Y271 | 1/20 | 0.55 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2806982 | 1.00 | MAOB (0.67) | MAOBMAOACYSLTR2BCHEHSP90AA1 | |
| SCHEMBL30384330 | 1.00 | MAOB (0.67) | MAOBMAOACYSLTR2BCHEHSP90AA1 | |
| SCHEMBL30383347 | 1.00 | MAOB (0.67) | MAOBMAOACYSLTR2BCHEHSP90AA1 | |
| SCHEMBL2803601 | 0.87 | MAOB (0.69) | MAOBMAOABCHEAPP | |
| SCHEMBL25221853 | 0.87 | MAOB (0.69) | MAOBMAOABCHEAPP | |
| SCHEMBL25202410 | 0.87 | MAOB (0.69) | MAOBMAOABCHEAPP | |
| SCHEMBL25198785 | 0.87 | MAOB (0.69) | MAOBMAOABCHEAPP | |
| SCHEMBL2803606 | 0.87 | MAOB (0.69) | MAOBMAOABCHEAPP | |
| SCHEMBL25185082 | 0.87 | MAOB (0.69) | MAOBMAOABCHEAPP | |
| SCHEMBL25196468 | 0.87 | MAOB (0.69) | MAOBMAOABCHEAPP |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 16 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | YEWSAVIN INC (US) | 2026-01-15 | — | — | US | disclosed |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | YewSavin, Inc. (US) | 2025-07-01 | — | — | US | disclosed |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-06-22 | — | — | US | disclosed |
| WO-2023086388-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | YewSavin, Inc. (US) | 2023-05-19 | — | — | WO | disclosed |
| EP-2538914-B1 | COSMETIC COMPOSITION COMPRISING A SUPERABSORBENT POLYMER AND AT LEAST A GEMINI SURFACTANT | ORÉAL L (FR) | 2016-06-15 | — | — | EP | disclosed |
| US-9364690-B2 | Composition comprising a superabsorbent polymer and a gemini surfactant | L'OREAL (FR) | 2016-06-14 | — | — | US | disclosed |
| US-20160067160-A1 | USE OF A 2-METHYLSUCCINIC ACID DIESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS CONTAINING THE SAME | OREAL (FR) | 2016-03-10 | — | — | US | disclosed |
| US-20150224046-A1 | COMPOSITION CONTAINING A SUPERABSORBENT POLYMER AND AN ORGANIC UV SCREENING AGENT | L'OREAL (FR) | 2015-08-13 | — | — | US | disclosed |
| EP-2482793-B1 | USE OF PIPERIDINE ESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS COMPRISING IT | ORÉAL L (FR) | 2015-04-22 | — | — | EP | disclosed |
| US-8716311-B2 | Use of piperidine ester derivative as solvent in cosmetic compositions; cosmetic compositions comprising it | L'OREAL (FR) | 2014-05-06 | — | — | US | disclosed |
| US-20140056832-A1 | USE OF A 2-METHYLSUCCINIC ACID DIESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS CONTAINING THE SAME | L'OREAL (FR) | 2014-02-27 | — | — | US | disclosed |
| US-20130039963-A1 | COMPOSITION COMPRISING A SUPERABSORBENT POLYMER AND A GEMINI SURFACTANT | L'OREAL (FR) | 2013-02-14 | — | — | US | disclosed |
| US-20120282197-A1 | USE OF PIPERIDINE ESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS COMPRISING IT | L'OREAL (FR) | 2012-11-08 | — | — | US | disclosed |
| US-20120269746-A1 | USE OF CAPROLACTAM DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS COMPRISING IT | L'OREAL (FR) | 2012-10-25 | — | — | US | disclosed |
| US-20100330018-A1 | COMPOSITION CONTAINING A SUPERABSORBENT POLYMER AND AN ORGANIC UV SCREENING AGENT | L'OREAL (FR) | 2010-12-30 | — | — | US | disclosed |
| US-20100143276-A1 | Ester solvents derived from 4-carboxy-2-pyrrolidinone formulated into UV-screening cosmetic compositions | L'OREAL (FR) | 2010-06-10 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (11 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20140056832-A1 | USE OF A 2-METHYLSUCCINIC ACID DIESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS CONTAINING THE SAME | DIMT1, MAT2A, SCD | MAOB 1478/4885MAOA 959/4885CYSLTR2 460/4885 |
| US-20260014100-A1 | Compositions and Methods for Treating Bleeding and Bleeding Disorders | SERPINC1, F2, F13B | MAOB 1004/4885MAOA 1902/4885CYSLTR2 3789/4885 |
| US-20230190679-A1 | COMPOSITIONS AND METHODS FOR TREATING BLEEDING AND BLEEDING DISORDERS | SERPINC1, SERPINE1, SERPINH1 | MAOB 2435/4885MAOA 3145/4885CYSLTR2 2710/4885 |
| US-20150224046-A1 | COMPOSITION CONTAINING A SUPERABSORBENT POLYMER AND AN ORGANIC UV SCREENING AGENT | KRT18, FABP2, FABP4 | MAOB 1681/4885MAOA 762/4885CYSLTR2 2901/4885 |
| US-12343317-B2 | Compositions and methods for treating bleeding and bleeding disorders | SERPINC1, SERPINE1, SERPINH1 | MAOB 2435/4885MAOA 3145/4885CYSLTR2 2710/4885 |
| US-20120282197-A1 | USE OF PIPERIDINE ESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS COMPRISING IT | PLD1, PLD2, FFAR1 | MAOB 912/4885MAOA 863/4885CYSLTR2 409/4885 |
| US-20160067160-A1 | USE OF A 2-METHYLSUCCINIC ACID DIESTER DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS CONTAINING THE SAME | DIMT1, FADS2, SCD | MAOB 1280/4885MAOA 856/4885CYSLTR2 437/4885 |
| US-20100330018-A1 | COMPOSITION CONTAINING A SUPERABSORBENT POLYMER AND AN ORGANIC UV SCREENING AGENT | KRT18, FABP2, FABP4 | MAOB 1681/4885MAOA 762/4885CYSLTR2 2901/4885 |
| US-20120269746-A1 | USE OF CAPROLACTAM DERIVATIVE AS SOLVENT IN COSMETIC COMPOSITIONS; COSMETIC COMPOSITIONS COMPRISING IT | DEGS1, CAPN1, PPT1 | MAOB 1060/4885MAOA 787/4885CYSLTR2 815/4885 |
| US-20100143276-A1 | Ester solvents derived from 4-carboxy-2-pyrrolidinone formulated into UV-screening cosmetic compositions | FASN, ALOX12, PAH | MAOB 959/4885MAOA 1283/4885CYSLTR2 460/4885 |
| US-20130039963-A1 | COMPOSITION COMPRISING A SUPERABSORBENT POLYMER AND A GEMINI SURFACTANT | SGMS2, SGMS1, SCO2 | MAOB 1674/4885MAOA 1732/4885CYSLTR2 1488/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.